Internal Medicine, Rheumatology · Tustin, CA
NPI
1619972510
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
12791 Newport Ave, Suite 201
Tustin, CA, 92780
Phone (714) 505-5500
Groups this clinician bills Medicare through
Medicare paid, 2024
$380K
7,270 services
Medicare patients, 2024
1,398
Average age 76
Drug cost, 2024
$4.5M
7,144 prescriptions
Company payments, 2025
$182K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robin K Dore was code J1010 (injection, methylprednisolone acetate, 1 mg), 2,806 times for 32 patients. In total Robin K Dore billed 7,270 services in 20 codes, and Medicare paid $380K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,806 | 32 | $0.10 | $281 |
| 99214 Office E&M - Established | Office | 1,681 | 919 | $101.77 | $171K |
| 99213 Office E&M - Established | Office | 1,053 | 660 | $63.33 | $67K |
| 99442 Telephone Services | Office | 393 | 283 | $66.28 | $26K |
| 99215 Office E&M - Established | Office | 377 | 241 | $149.74 | $56K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 294 | 236 | $13.49 | $3,965 |
| 99443 Telephone Services | Office | 283 | 194 | $104.17 | $29K |
| 77080 Standard X-ray | Office | 123 | 122 | $43.86 | $5,395 |
| 99204 Office E&M - New | Office | 65 | 65 | $133.47 | $8,675 |
| 99203 Office E&M - New | Office | 50 | 50 | $84.84 | $4,242 |
| 96372 Injection Administration | Office | 30 | 14 | $10.00 | $300 |
| 99205 Office E&M - New | Office | 29 | 29 | $169.39 | $4,912 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 27 | 14 | $6.55 | $177 |
| 20552 Musculoskeletal | Office | 19 | 14 | $42.78 | $813 |
| 99441 Telephone Services | Office | 18 | 18 | $48.82 | $879 |
By year: 2022 $395K for 5,522 services; 2023 $254K for 3,730 services; 2024 $380K for 7,270 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 586 | 410 | $4.90 | $2,871 |
Medicare prescription drug claims, 2024
In 2024, the drug Robin K Dore prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 724 prescriptions and refills. In total Robin K Dore wrote 7,144 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 724 | 1,654 | 188 | $33K |
| Sulfasalazine Generic | 373 | 829 | 103 | $10K |
| Methotrexate Methotrexate Sodium | 341 | 756 | 86 | $14K |
| Celecoxib Generic | 284 | 597 | 74 | $13K |
| Tramadol Hcl Generic | 272 | 290 | 56 | $4,524 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 253 | 253 | 39 | $9,252 |
| Prednisone Generic | 238 | 551 | 69 | $2,684 |
| Meloxicam Generic | 237 | 605 | 73 | $1,401 |
| Leflunomide Generic | 210 | 475 | 63 | $17K |
| Allopurinol Generic | 195 | 569 | 57 | $2,061 |
| Gabapentin Generic | 189 | 452 | 57 | $3,338 |
| Raloxifene Hcl Generic | 186 | 532 | 58 | $8,667 |
| Diclofenac Sodium Generic | 182 | 357 | 71 | $14K |
| Alendronate Sodium Generic | 176 | 466 | 59 | $1,141 |
| Risedronate Sodium Generic | 165 | 481 | 58 | $14K |
Brand drugs: 1,090 claims; generic drugs: 5,991 claims; opioid claims: 623.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robin K Dore $182K ($182K in general payments such as food, travel and fees) from 21 companies. The largest payer was UCB, Inc. with $47K.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 59 | $47K |
| Abbvie Inc. ABBV | 58 | $38K |
| Kyowa Kirin, Inc. 4151.T | 49 | $37K |
| Amgen Inc. AMGN | 78 | $21K |
| Janssen Biotech, Inc. JNJ | 24 | $20K |
| Tonix Medicines, Inc. | 5 | $11K |
| Alexion Pharmaceuticals, Inc. AZN | 6 | $4,135 |
| Invivyd Inc IVVD | 2 | $1,658 |
| Sobi, Inc SOBI.ST | 4 | $526 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $377 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.